Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says

[ad_1] The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to…

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of…

Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

[ad_1] President Joe Biden speaks during an event at the National Institutes of Health in Bethesda,…

Healthy Returns: The first round of Medicare drug price negotiations is nearing an end

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of…

This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A

[ad_1] Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class…

A corner of the cancer therapy market is heating up—Here are the names investors need to know

[ad_1] There’s been a lot of attention lately on a corner of the oncology market called…

Stocks making the biggest premarket moves: General Motors, GE Aerospace, Novartis, JetBlue and more

[ad_1] Check out the companies making the biggest moves in premarket trading: General Motors — The…

Biden administration unveils first 10 drugs subject to Medicare price negotiations

[ad_1] The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject…

The ADHD drug market is already stretched thin. Now it’s facing a back-to-school supply strain

[ad_1] Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire Plc. Jb Reed |…